Michael A. Gillette

75.6k citations

45 papers · 40.3k indexed · 4 hit papers · h-index 26

Impact in

Cancer Research top 0.05%
- Cancer-related molecular mechanisms research
Molecular Biology top 0.05%
- RNA modifications and cancer
- Bioinformatics and Genomic Networks
- Gene expression and cancer classification
- Epigenetics and DNA Methylation
- RNA Research and Splicing

Papers in

Spectroscopy 18
- Advanced Proteomics Techniques and Applications 18
- Mass Spectrometry Techniques and Applications 4
Family Practice 1

Co-authors: Eric S. Lander Todd R. Golub Amanda G. Paulovich Jill P. Mesirov Pablo Tamayo Benjamin L. Ebert Vamsi K. Mootha Scott L. Pomeroy
Journals: Molecular & Cellular Proteomics (8 papers)Journal of Stroke and Cerebrovascular Diseases (4 papers)Proceedings of the National Academy of Sciences (3 papers)Nature Methods (2 papers)Annals of Pharmacotherapy (2 papers)
Partner nations: United States Spain Mozambique

In The Last Decade

Michael A. Gillette

42 papers receiving 39.9k citations

Hit Papers

align trajectories log scale

Integrated proteomic analysis of post-translational modifications by serial enrichment 2013 · 471 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2013 Nature Methods
2006 Nature Biotechnology
2005 Proceedings of the National Academy of Sciences
2001 Proceedings of the National Academy of Sciences

Peers

Countries citing papers authored by Michael A. Gillette

Since Specialization

Citations

This map shows the geographic impact of Michael A. Gillette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael A. Gillette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael A. Gillette more than expected).

Fields of papers citing papers by Michael A. Gillette

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael A. Gillette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael A. Gillette. The network helps show where Michael A. Gillette may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Michael A. Gillette, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michael A. Gillette Line = papers co-authored together Michael A. Gillette links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High-Throughput Proteomic and Phosphoproteomic Analysis of Formalin-Fixed Paraffin-Embedded Tissues Molecular & Cellular Proteomics ·Moe Haines, S Vasojevic, Celeste C. Wells, Claudia Ctortecka, Chelsea J. Newton, Daniel C. Rohrer, Galen Hostetter, D.R. Mani, Michael A. Gillette, Shankha Satpathy, Steven A. Carr	2025	0
2	Multifaceted Intervention to Improve P2Y12 Inhibitor Adherence After Percutaneous Coronary Intervention: A Stepped Wedge Trial Journal of the American Heart Association ·P. Michael Ho, Colin O’Donnell, Marina McCreight, Anthony A. Bavry, Hayden B. Bosworth, Saket Girotra, Paul Grossman, Christian D. Helfrich, Faisal Latif, David Lu, Michael E. Matheny, Kreton Mavromatis, Hendra Tri Cahyono, Nadine David, M. Ravindar, Gary K. Grunwald, Michael A. Gillette, Hani Jneid	2022	4
3	Cancer proteogenomics: current impact and future prospects Nature reviews. Cancer ·D.R. Mani, Karsten Krug, Bing Zhang, Shankha Satpathy, Karl R. Clauser, Li Ding, Matthew J. Ellis, Michael A. Gillette, Steven A. Carr	2022	119
4	Abstract 16: Patterns and regulation of post translational modifications in cancer Cancer Research ·Yifat Geffen, Shankara Anand, Yo Akiyama, 大剛椋木, Alexander Kerelsky, Jared L. Johnson, Karsten Krug, David I. Heiman, Shankha Satpathy, Karl R. Clauser, Michael A. Gillette, D.R. Mani, Chet Birger, Steven A. Carr, Lewis C. Cantley, François Aguet, Gad Getz	2021	1
5	Biomarkers to Distinguish Bacterial From Viral Pediatric Clinical Pneumonia in a Malaria-Endemic Setting Clinical Infectious Diseases ·Michael A. Gillette, D.R. Mani, Joseph A. Giambrone, Karell G. Pellé, Lola Madrid, Sozinho Acácio, Miguel Lanaspa, Pedro L. Alonso, Clarissa Valim, Steven A. Carr, S. F. Schaffner, G. Parrini, Danny A. Milner, Quique Bassat, Dyann F. Wirth	2020	13
6	Acute Tubular Injury in a Patient on a Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor SHILAP Revista de lepidopterología ·HaoYu Ding, Maulin Shah, Michael A. Gillette, Peter P. Jones, Salim S. Virani, Christie M. Ballantyne, Vijay Nambi	2020	4
7	Quantitative, multiplexed workflow for deep analysis of human blood plasma and biomarker discovery by mass spectrometry Nature Protocols ·Hasmik Keshishian, Michael Burgess, Harrison Specht, Qipeng Wei, Karl R. Clauser, Michael A. Gillette, Steven A. Carr	2017	125
8	Transcriptional categorization of the etiology of pneumonia syndrome in pediatric patients in malaria endemic areas The Journal of Infectious Diseases ·Jacob Silterra, Michael A. Gillette, Miguel Lanaspa, Karell G. Pellé, Clarissa Valim, Rushdy Ahmad, Sozinho Acácio, Grzegorz Włażewski, Yan Tan, Lola Madrid, Pedro L. Alonso, Steven A. Carr, Roger C. Wiegand, Quique Bassat, Jill P. Mesirov, Danny A. Milner, Dyann F. Wirth	2016	10
9	Creation of a Human Secretome: A Novel Composite Library of Human Secreted Proteins: Validation Using Ovarian Cancer Gene Expression Data and a Virtual Secretome Array Clinical Cancer Research ·Vinod Vathipadiekal, Victoria Wang, Wei Wei, Levi Waldron, Ronny Drapkin, Michael A. Gillette, Steven J. Skates, Michael J. Birrer	2015	69
10	Responses to Bacteria, Virus, and Malaria Distinguish the Etiology of Pediatric Clinical Pneumonia American Journal of Respiratory and Critical Care Medicine ·Clarissa Valim, Rushdy Ahmad, Miguel Lanaspa, Yan Tan, Sozinho Acácio, Michael A. Gillette, Grzegorz Włażewski, Danny A. Milner, Lola Madrid, Karell G. Pellé, Jaroslaw Harezlak, Jacob Silterra, Pedro L. Alonso, Steven A. Carr, Jill P. Mesirov, Dyann F. Wirth, Roger C. Wiegand, Quique Bassat	2015	29
11	Multiplexed, Quantitative Workflow for Sensitive Biomarker Discovery in Plasma Yields Novel Candidates for Early Myocardial Injury Molecular & Cellular Proteomics ·Hasmik Keshishian, Michael Burgess, Michael A. Gillette, Philipp Mertins, Karl R. Clauser, D.R. Mani, Eric Kuhn, Laurie Farrell, Robert E. Gerszten, Steven A. Carr	2015	158
12	Persistent Leukocytosis—Is this a Persistent Problem for Patients with Acute Ischemic Stroke? Journal of Stroke and Cerebrovascular Diseases ·Amelia K. Boehme, Andre Kumar, Michael Lyerly, Michael A. Gillette, James E. Siegler, Karen C. Albright, T. Mark Beasley, Sheryl Martin‐Schild	2014	16
13	Simplified and Efficient Quantification of Low-abundance Proteins at Very High Multiplex via Targeted Mass Spectrometry Molecular & Cellular Proteomics ·Michael Burgess, Hasmik Keshishian, D.R. Mani, Michael A. Gillette, Steven A. Carr	2014	55
14	Connecting Genomic Alterations to Cancer Biology with Proteomics: The NCI Clinical Proteomic Tumor Analysis Consortium Cancer Discovery ·Matthew J. Ellis, Michael A. Gillette, Steven A. Carr, Amanda G. Paulovich, Richard Smith, А. Л. Васильев, R. Reid Townsend, Christopher R. Kinsinger, Mehdi Mesri, Henry Rodriguez, D.C. Liebler	2013	215
15	Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry Nature Methods ·Michael A. Gillette, Steven A. Carr	2012	352
16	What Change in the National Institutes of Health Stroke Scale Should Define Neurologic Deterioration in Acute Ischemic Stroke? Journal of Stroke and Cerebrovascular Diseases ·James E. Siegler, Amelia K. Boehme, Andre Kumar, Michael A. Gillette, Karen C. Albright, Sheryl Martin‐Schild	2012	95
17	A Human Proteome Detection and Quantitation Project Molecular & Cellular Proteomics ·N. Leigh Anderson, Norman G. Anderson, Terry W. Pearson, Christoph H. Borchers, Amanda G. Paulovich, Scott D. Patterson, Michael A. Gillette, Ruedi Aebersold, Steven A. Carr	2009	149
18	Accurate Inclusion Mass Screening Molecular & Cellular Proteomics ·Jacob D. Jaffe, Hasmik Keshishian, Betty Chang, Theresa A. Addona, Michael A. Gillette, Steven A. Carr	2008	121
19	Protein biomarker discovery and validation: the long and uncertain path to clinical utility Nature Biotechnology ·Nader Rifai, Michael A. Gillette, Steven A. Carr Hit paper breakdown →	2006	1370
20	Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles Proceedings of the National Academy of Sciences ·Aravind Subramanian, Pablo Tamayo, Vamsi K. Mootha, Sayan Mukherjee, Benjamin L. Ebert, Michael A. Gillette, Amanda G. Paulovich, Scott L. Pomeroy, Todd R. Golub, Eric S. Lander, Jill P. Mesirov Hit paper breakdown →	2005	33983

About Michael A. Gillette

Michael A. Gillette is a scholar working on Spectroscopy, Family Practice, Neurology, Anesthesiology and Pain Medicine and Molecular Biology, having authored 45 papers that have together received 40.3k indexed citations. Recurring topics across this work include Advanced Proteomics Techniques and Applications (18 papers), Acute Ischemic Stroke Management (6 papers), Bioinformatics and Genomic Networks (5 papers), Machine Learning in Bioinformatics (4 papers), Mass Spectrometry Techniques and Applications (4 papers), Gene expression and cancer classification (4 papers), Antiplatelet Therapy and Cardiovascular Diseases (4 papers) and Traumatic Brain Injury and Neurovascular Disturbances (4 papers). The work is most often cited by research in Cancer Research (8.4k citations), Molecular Biology (25.8k citations), Immunology (6.1k citations), Oncology (6.5k citations) and Pulmonary and Respiratory Medicine (6.1k citations). Michael A. Gillette has collaborated with scholars based in United States, Spain and Mozambique. Frequent co-authors include Eric S. Lander, Todd R. Golub, Amanda G. Paulovich, Jill P. Mesirov, Pablo Tamayo, Benjamin L. Ebert, Vamsi K. Mootha, Scott L. Pomeroy, Sayan Mukherjee and Aravind Subramanian. Their work appears in journals such as Molecular & Cellular Proteomics, Journal of Stroke and Cerebrovascular Diseases, Proceedings of the National Academy of Sciences, Nature Methods and Annals of Pharmacotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact